ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
98,240.60
0.20%
S&P 500
5,969.34
0.35%
Dow Jones
44,296.51
0.97%
US Dollar vs Yen
154.416
-0.23%
Brent Oil
74.515
-0.34%
Registration Strip Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ
  6. Belite Bio Inc (BLTE)

  7. Belite Bio Inc (BLTE) ニュース

BLTE

Belite Bio (BLTE)

Belite Bio Inc
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:BLTE
日付受信時刻ニュースソース見出しコード企業名
2024/11/2108 : 25Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:BLTEBelite Bio Inc
2024/11/2008 : 17Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:BLTEBelite Bio Inc
2024/11/1215 : 00GlobeNewswire Inc.Belite Bio Reports Third Quarter 2024 Financial Results and Provides a Corporate UpdateNASDAQ:BLTEBelite Bio Inc
2024/11/0522 : 00GlobeNewswire Inc.Belite Bio to Host Webcast on November 12, 2024, to Discuss Third Quarter 2024 Financial ResultsNASDAQ:BLTEBelite Bio Inc
2024/11/0420 : 02Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:BLTEBelite Bio Inc
2024/11/0406 : 00GlobeNewswire Inc.Belite Bio Announces Exercise of Warrants for US$28.75 Million Gross ProceedsNASDAQ:BLTEBelite Bio Inc
2024/10/1421 : 00GlobeNewswire Inc.Belite Bio Announces Presentations at the American Academy of Ophthalmology 2024 Annual MeetingNASDAQ:BLTEBelite Bio Inc
2024/10/0906 : 48Edgar (US Regulatory)Form 144/A - Report of proposed sale of securities: [Amend]NASDAQ:BLTEBelite Bio Inc
2024/10/0906 : 46Edgar (US Regulatory)Form 144/A - Report of proposed sale of securities: [Amend]NASDAQ:BLTEBelite Bio Inc
2024/10/0821 : 00GlobeNewswire Inc.Belite Bio to Participate in the Maxim Group 2024 Healthcare Virtual SummitNASDAQ:BLTEBelite Bio Inc
2024/10/0409 : 50Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:BLTEBelite Bio Inc
2024/10/0409 : 48Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:BLTEBelite Bio Inc
2024/10/0119 : 03Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:BLTEBelite Bio Inc
2024/09/2621 : 51GlobeNewswire Inc.Deutsche Bank ADR Virtual Investor Conference: Presentations Now Available for Online ViewingNASDAQ:BLTEBelite Bio Inc
2024/09/2101 : 40Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:BLTEBelite Bio Inc
2024/09/1800 : 22GlobeNewswire Inc.International companies to host live webcasts at Deutsche Bank’s Depositary Receipts Virtual Investor Conference on September 24th and 25th, 2024NASDAQ:BLTEBelite Bio Inc
2024/09/1021 : 00GlobeNewswire Inc.Belite Bio Announces First Patient Dosed in Phase 2/3 DRAGON II Trial of Tinlarebant for the Treatment of Stargardt DiseaseNASDAQ:BLTEBelite Bio Inc
2024/09/0501 : 29Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:BLTEBelite Bio Inc
2024/09/0321 : 00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:BLTEBelite Bio Inc
2024/09/0321 : 00GlobeNewswire Inc.Belite Bio to Participate in Three Upcoming Investor ConferencesNASDAQ:BLTEBelite Bio Inc
2024/09/0121 : 00GlobeNewswire Inc.Belite Bio Announces Appointment of Hendrik P. N. Scholl, MD, MA, as Chief Medical OfficerNASDAQ:BLTEBelite Bio Inc
2024/08/1707 : 24Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:BLTEBelite Bio Inc
2024/08/1505 : 32Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:BLTEBelite Bio Inc
2024/08/1505 : 30Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:BLTEBelite Bio Inc
2024/08/1503 : 38Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:BLTEBelite Bio Inc
2024/08/1005 : 30Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:BLTEBelite Bio Inc
2024/08/1005 : 30GlobeNewswire Inc.Belite Bio Reports Second Quarter 2024 Financial Results and Provides a Corporate UpdateNASDAQ:BLTEBelite Bio Inc
2024/08/0821 : 00GlobeNewswire Inc.Belite Bio to Present at the H.C. Wainwright 4th Annual Ophthalmology Virtual ConferenceNASDAQ:BLTEBelite Bio Inc
2024/08/0608 : 10GlobeNewswire Inc.Belite Bio to Host Webcast on August 12, 2024, to Discuss Second Quarter 2024 Financial ResultsNASDAQ:BLTEBelite Bio Inc
2024/07/0821 : 00GlobeNewswire Inc.Belite Bio to Present at the JonesHealthcare Seaside SummitNASDAQ:BLTEBelite Bio Inc
 Showing the most relevant articles for your search:NASDAQ:BLTE

最近閲覧した銘柄

USOTC
RHHBY
Roche (QX)
NYSE
JPM
JP Morgan Chase
COIN
DOGEUSD
Dogecoin
USOTC
DTEGY
Deutsche Telekom (QX)
CCOM
US30
US 30
NYSE
XOM
Exxon Mobil
COIN
XRPUSD
Ripple
FX
USDJPY
US Dollar vs Yen
FX
USDEUR
US Dollar vs Euro
NYSE
NKE
Nike
USOTC
BNPQY
BNP Paribas (QX)
NYSE
MCD
McDonalds
USOTC
BASFY
BASF (QX)
NYSE
CVX
Chevron
NYSE
VZ
Verizon Communications
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

日本
会社情報
ビジネス
人気
アプリを入手
App Store
Google Play

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有